| __timestamp | BioCryst Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 122000 | 5903000 |
| Thursday, January 1, 2015 | 1896000 | 2762000 |
| Friday, January 1, 2016 | 2699000 | 1114000 |
| Sunday, January 1, 2017 | 1702000 | 25573000 |
| Monday, January 1, 2018 | 471000 | 6000000 |
| Tuesday, January 1, 2019 | 4101000 | 38845000 |
| Wednesday, January 1, 2020 | 1676000 | 50523000 |
| Friday, January 1, 2021 | 7264000 | 75463000 |
| Saturday, January 1, 2022 | 6594000 | 105767000 |
| Sunday, January 1, 2023 | 4661000 | 167512000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. From 2014 to 2023, Xenon Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc. have shown contrasting trends in their cost of revenue. Xenon Pharmaceuticals has seen a staggering increase, with costs rising from approximately $5.9 million in 2014 to $167.5 million in 2023, marking a growth of over 2700%. In contrast, BioCryst Pharmaceuticals experienced a more modest increase, with costs peaking at $7.3 million in 2021 before settling at $4.7 million in 2023, reflecting a more stable cost management strategy.
This data highlights the dynamic nature of cost management in the pharmaceutical industry, where strategic financial planning can significantly impact a company's bottom line. As the industry evolves, understanding these trends becomes crucial for stakeholders aiming to optimize operational efficiency.
Cost of Revenue Trends: Sanofi vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Comparison: Biogen Inc. vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs BioCryst Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Bio-Techne Corporation and Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs BioCryst Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.